pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·6h ago·1 min read
save

Scientists awarded 2026 Nobel Prize for pioneering optogenetics light-switch technique

Oct 5, 2026·read at Fierce Biotech ↗Positive

The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for their work on optogenetics, a technique that uses light to control neurons.

The method relies on light-gated ion channels, specifically channelrhodopsin, which was identified through studies of the algae Chlamydomonas. Hegemann discovered the gene for a light-sensitive protein, and together with Nagel they characterized the channel that opens in response to specific wavelengths.

Optogenetics has become a widely adopted tool for investigating brain function and behavior, enabling precise activation or inhibition of targeted neuronal populations in research settings.

The Nobel Committee highlighted the impact of these discoveries on neuroscience and potential therapeutic approaches, underscoring the technique's relevance to future drug development.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or Medicine”

read at Fierce Biotech ↗
805 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
IONIS PHARMACEUTICALS INC2Beam Therapeutics Inc.GenSight Biologics SANOVARTISNanoscope Therapeutics IncRay Therapeutics IncStanford University
topics
Ophthalmology6Gene Therapy (AAV)2Alzheimer's DiseaseBig PharmaCell TherapyEpilepsy

related stories

  • Dec 23Fierce Biotech Layoff Tracker 2026: Foghorn cuts workforce by 40%; BioMarin drops 117 rolesFierce Biotech
  • Dec 22Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71MFierce Biotech
  • 2d agoFoghorn cuts 40% of workforceBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 3d agoChutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOFierce Biotech